Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India

Infection, Genetics and Evolution

Volumn 10, Issue 8, 2010, Pages 1188-1198

  Agrawal, Anurodh S ^a   Sarkar, Mehuli ^a   Ghosh, Swati ^a   Roy, Tapasi ^a   Chakrabarti, Sekhar ^a   Lal, Renu ^b   Mishra, Akhilesh C ^c   Chadha, Mandeep S ^c   Chawla Sarkar, Mamta ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b Global Disease Detection Program   (India)

^c NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

Amino acid; H275Y; Influenza; Kolkata; Mutation; Nucleotide; Oseltamivir; Resistance; Surveillance; Vaccine

Indexed keywords

OSELTAMIVIR; PROTEIN HA1; PROTEIN NA; SIALIDASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIVIRAL RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE SURVEILLANCE; EPIDEMIC; GLYCOSYLATION; HUMAN; INDIA; INFANT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEASONAL VARIATION; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; BASE SEQUENCE; DRUG RESISTANCE, VIRAL; GENETIC VARIATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INDIA; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; OSELTAMIVIR; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; VIRAL PROTEINS;

INFLUENZA A VIRUS;

EID: 77957317449     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2010.07.019     Document Type: Article

References (32)

1. Abe Y., Takashita E., Sugawara K., Matsuzaki Y., Muraki Y., Hongo S. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J. Virol. 2004, 78:9605-9611.
2. Agrawal A.S., Sarkar M., Chakrabarti S., Rajendran K., Kaur H., Mishra A.C., Chatterjee M.K., Naik T.N., Chadha M.S., Chawla-Sarkar M. Comparative evaluation of real-time PCR and conventional RT-PCR during 2 year surveillance for influenza and respiratory syncytial virus among children with acute respiratory infections in Kolkata, India, reveals a distinct seasonality of infection. J. Med. Microbiol. 2009, 58:1616-1622.
3. Ahmad O.B., Lopez A.D., Inoue M. The decline in child mortality: a reappraisal. Bull. W.H.O. 2000, 78:1175-1191.
4. Beak Y.H., Park J.H., Song Y.J., Song M., Pascua P.N.Q., Hahn Y., Han H., Lee O., Kim K., Kang C., Choi Y. Molecular characterization and phylogenetic analysis of H3N2 human Influenza A viruses in Cheongju, South Korea. J. Microbiol. 2009, 47:91-100.
5. Bragstad K., Nielsen L.P., Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol. J. 2008, 5:1-19.
6. Bulimo W.D., Garner J.L., Schnabel D.C., Bedno S.A., Njenga M.K., Ochieng W.O., Amukoye E., Magana J.M., Simwa J.M., Ofula V.O., Lifumo S.M., Wangui J., Breiman R.F., Martin S.K. Genetic analysis of H3N2 influenza A viruses isolated in 2006-2007 in Nairobi, Kenya. Influenza Other Respiratory Viruses 2008, 2:107-113.
7. Chan M. World Now at the Start of 2009 Influenza Pandemic 2009, W.H.O.
8. Colman P.M. Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci. 1994, 3:1687-1696.
9. Colman P.M., Hoyne P.A., Lawrence M.C. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J. Virol. 1993, 67:2972-2980.
10. European Centre for Disease Prevention and Control Emergence of seasonal influenza viruses type A (H1N1) with oseltamivir resistance in some European Countries at the start of the 2007-2008 influenza season. Interim ECDC Risk 2008, Assessment January 28.
11. Fanning T.G., Reid A.H., Taubenberger J.K. Influenza A virus neuraminidase: regions of the protein potentially involved in virus-host interactions. Virology 2000, 276:417-423.
12. Fedson D.S., Hirota Y., Shin H.K., Cambillard P.E., Kiely J., Ambrosch F., Hannoun C., Leese J., Sprenger M.J., Hampson A.W., Bro-Jørgensen K., Ahlbom A.M., Nøkleby H., Valle M., Olafsson O., Salmerón F., Cloetta J., Rebelo de Andrade H., Snacken R., Donatelli I., Jennings L.C., Strikas R.A. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine 1997, 15:1506-1511.
13. Gianfrani C., Oseroff C., Sidney J., Chesnut R.W., Sette A. Human memory CTL response specific for influenza A virus is broad and multispecific. Hum. Immunol. 2000, 61:438-452.
14. Gubareva L.V., Kaiser L., Hayden F.G. Influenza virus neuraminidase inhibitors. Lancet 2000, 355:827-835.
15. Hansen J.E., Lund O., Engelbrecht J., Bohr H., Nielsen J.O. Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc: polypeptide N-acetylgalactosaminyl transferase. Biochem. J. 1995, 308:801-813.
16. Hoffmann E., Stech J., Guan Y., Webster R.G., Perez D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 2001, 146:2275-2289.
17. Ives J.A., Carr J.A., Mendel D.B., Tai C.Y., Lambkin R., Kelly L., Oxford J.S., Hayden F.G., Roberts N.A. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res. 2002, 55:307-317.
18. Kiso M., Mitamura K., Sakai-Tagawa Y., Shiraishi K., Kawakami C., Kimura K., Hayden F.G., Sugaya N., Kawaoka Y. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004, 364:759-776.
19. Knossow M., Skehel J.J. Variation and infectivity neutralization in influenza. Immunology 2006, 119:1-7.
20. Lackenby A., Hungnes O., Dudman S.G., Meijer A., Paget W.J., Hay A.J., Zambon M.C. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Euro. Surveill. 2008, 13(5):1-2.
21. Li D., Saito R., Le M.T.Q., Nguyen H.L.K., Suzuki Y., Shobugawa Y., Dinh D.T., Hoang P.V.M., Tran H.T.T., Nghiem H.K., Hoang L.T., Huynh L.P., Nguyen H.T., Nishikawa M., Suzuki H. Genetic analysis of Influenza A/H3N2 and A/H1N1 viruses circulating in Vietnam from 2001 to 2006. J. Clin. Microbiol. 2008, 46:399-405.
22. Lindstrom S., Sugita S., Endo A., Ishida M., Huang P., Xi S.H., Nerome K. Evolutionary characterization of recent human H3N2 influenza A isolates from Japan and China: novel changes in the receptor binding domain. Arch. Virol. 1996, 141:1349-1355.
23. Nelson M.I., Simonsene L., Viboud C., Miller M.A., Holmes E.C. Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathogens 2007, 3:1220-1228.
24. Page R.D.M. Tree View: an application to display Phylogenetic trees on personal computers. Comput. Appl. Biol. Sci. 1996, 12:357-358.
25. Parrish C.R., Kawaoka Y. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu. Rev. Microbiol. 2005, 59:553-586.
26. Plotkin J.B., Dushoff J. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7152-7157.
27. Reddaiah V.P., Kapoor S.K. Acute respiratory infections in rural under fives. Ind. J. Pediatr. 1988, 35:424-426.
28. Suzuki Y. Natural selection on the influenza virus genome. Mol. Bio. Evol. 2006, 23:1902-1911.
29. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25:4876-4882.
30. Wiley D.C., Wilson I.A., Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981, 289:373-378.
31. Williams B.G., Gouws E., Boschi-Pinto C., Bryce J., Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect. Dis. 2002, 2:25-32.
32. Xu X., Smith C.B., Mungall B.A., Lindstrom S.E., Hall H.E., Subbarao K., Cox N.J., Klimov A. Intercontinental circulation of human influenza A (H1N2) reassortant viruses during the 2001-2002 influenza seasons. J. Infect. Dis. 2002, 186:1490-1493.